Global ETD Search

1	The effect of Aconitum napellus 30C on the occurrence and severity of adverse reactions following Diphtheria-Tetanus-Pertussis and Haemophilus influenzae type b immunisation Torline, John Ross 29 July 2009 (has links) M.Tech. Immunisation
2	Production of monoclonal antibodies to Bordetella pertussis as a means of identifying protective antigens Berry, P. R. January 1987 (has links) No description available. 610 Whooping cough immunisation
3	Liposomes as a gene delivery system Perrie, Yvonne January 1999 (has links) No description available. 572.8 Genetic immunisation; DNA
4	Characterisation of the immune response of mice to Mycobacterium leprae Stagg, A. J. January 1988 (has links) No description available. 611 Immunisation with M.leprae
5	Enhancement of subunit influenza vaccine with diptheria - tetanus - pertussis (DTP) vaccination Tamizifar, Hassan January 1996 (has links) No description available. 579 Immunisation; Influenza virus
6	The role of natural killer cells in respiratory syncytial virus infection of BALB/c mice Harrop, Jeremy Alexander January 1991 (has links) No description available. 579 Vaccines; Virology; Immunisation
7	Measles vaccination in Kenya : determination of vaccine coverage, determinants of receipt of vaccination and the quality of immunisation services in slum areas of Nairobi Borus, Peter Kimutai January 2002 (has links) No description available. 362.1 Under immunisation
8	Plasma procurement and clinical evaluation of an intravenous immunoglobulin preparation Lam Shang Leen, Clifford January 1987 (has links) No description available. 610 Immunisation against infection
9	Methods for the design and evaluation of East Coast fever (ECF) control strategies Kimera, Sharadhuli I. January 1998 (has links) No description available. 610 Immunisation; Theileriosis
10	Ethical aspects of immunisation services in South Africa: implications for legislation and policy review Ngcobo, Ntombenhle Judith 16 September 2009 (has links) Immunisation is the most cost-effective public health intervention currently available. However, immunisation raises ethical conflicts as it may be considered a public good with little individual benefits. Considering the effectiveness of immunisation in controlling vaccine preventable infections and the constant threat of outbreaks from conditions like measles, refusal to participate in a universal immunisation programme is morally questionable. This research analyses the ethical issues brought up by universal immunisation in South Africa. It focuses on local practice and on selected risk benefit issues. The research method used is literature search with analysis in the form of critical thinking and moral reasoning. The findings are that universal immunisation is ethically defensible based on various ethical theories and principles. South Africa’s experience with the 2003 -2005 measles outbreak points to a social contract for individuals to immunise their children. The argument of taking personal risk for public good and the no additional benefit argument once herd immunity is reached (presented by Dawson), are refuted. Risk-benefit elements for each infectious condition and vaccine are continually changing. This demands an ongoing assessment of risk-benefit issues for each vaccine and targeted infections to ensure the use of vaccines with optimal safety levels that are appropriate in South Africa. Recommendations are made on immunisation policy and legislation aimed at improving ethical practices of the immunisation service. Implementation of the recommendations will help ensure an immunisation programme that is proactive in addressing associated risks and should help eliminate litigation. The main recommendation of a legislated Compensation System for those who suffer severe adverse events following immunisation is directed at just distribution of benefits and burdens. immunisation services ethics South Africa

Search results